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Abstract
Coronaviruses are a large family and a subset of Coronaviridae that include common cold viruses and other severe diseases like
severe acute respiratory syndrome (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and coronavirus disease 2019 (COVID-
19). This is an ecological study based on statistics of the prevalence of coronavirus disease until 30 April 2020, based on the reports
sent to the World Health Organization (WHO). This study investigates the distribution of the incidence and trend of the incidence
rate of COVID-19 in countries, and its relation with the human development index (HDI) until 30 April 2020. The results showed that
the most cases of coronavirus disease until the mentioned date were in the United States of America (1,003,947 cases), Spain (212,917
cases), Italy (203,591 cases), the United Kingdom (165,225 cases), and Germany (159,119 cases), in sequence. The results exhibited a
significant positive correlation between the incidence of COVID-2019 and HDI in the world (r = 0.470, P < 0.0001).
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1. Context
Coronaviruses constitute a large family of viruses caus-
ing various diseases ranging from the common cold to
more severe diseases such as Middle East respiratory syn-
drome coronavirus (MERS-CoV) and severe acute respira-
tory syndrome coronavirus (SARS-CoV). The new coron-
avirus (nCoV) is the latest strain not recognized in indi-
viduals in the past (1). Coronaviruses are RNA viruses that
spread widely among humans, birds, and mammals that
make diseases in the liver and intestinal, respiratory, and
nervous systems. Coronaviruses are zoonotic pathogens
and are transmitted between animals and humans. Com-
prehensive examinations discovered that MERS-CoV was
transmitted from dromedary camels and SARS-CoV from
civet cats to humans. Some identified coronaviruses are
transmitted between animals, which have not infected hu-
mans yet (2, 3). General signs of the disease involve a
fever, shortness of breath, cough, respiratory symptoms,
and breathing problems. The infection can make severe
acute respiratory syndrome, kidney failure, pneumonia,
and even death in more severe cases (1, 4).
On 31 December 2019, some cases with severe acute res-
piratory infections were reported in Wuhan City, Hubei
Province of China. Based on primary observations, it
seemed that the patients had a history of work in the fish
and seafood market. The market was closed immediately
on 1 January 2020, and environmental sanitation and disin-
fection were carried out there completely. A few days later,
after the rejection of the diagnosis of seasonal influenza,
avian influenza, adenovirus, SARS coronavirus, and MERS
coronavirus, some other pathogens were identified. On 9
January, a virus was diagnosed as a causative agent of the
disease in 15 out of 59 hospitalized patients with Sarbe-
covirus, which raised great concern. The new coronavirus
shares about 50% of the genetic identity with SARS and is a
subset of Sarbecovirus (5).
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The virus has been briefly named nCoV-2019 to find out
more information. On 11 January 2020, the first deaths
from the virus were reported from China and the reports
of positive cases from other countries such as Thailand,
Japan, South Korea, and the United States by 20 January
and Person-to-person transfer to medical staff made the sit-
uation even more complicated. Yet, there is no appropri-
ate vaccine or treatment for 2019-nCoV, and therefore, hav-
ing a high clinical suspicion and questioning the history of
travel and contact with febrile patients and patients with
respiratory symptoms have a very important role in the
prevention and control of the disease (6). Standard pre-
cautions to avoid the spread of the infection involve cov-
ering the nose and mouth while sneezing and coughing,
frequent hand washing, boiling eggs and meat thoroughly,
and keeping away from close contact with anyone showing
the signs of respiratory disease like sneezing and cough-
ing.
2. Methods
As the number of incidences, remedies, and deaths
from the disease is changing daily and is being updated
based on the rates of diagnosis and reports from different
countries, the data in this article are based on the statistics
of the reports recorded by the WHO (30 April 2020) to ex-
amine the relationship between the incidence rate of the
disease and its relation to HDI in different countries (7).
2.1. Human Development Index
The human development index (HDI) that is released
by the World Bank gives the newest information on uni-
versal growth and involves national, regional, and univer-
sal estimations. Based on the human development report,
countries are classified into four categories based on hu-
man development, including very high, high, moderate,
and low classes. The HDI gives a value between zero and
one. The human development index allows comparisons
between countries. The HDI is a review of measures in hu-
man advance. The HDI determines the average success in a
nation in three major aspects of human progress, includ-
ing long and healthy life, access to knowledge, and living
standards (8-10).
2.2. Statistical Analysis
The extracted data were analyzed by the bivariate cor-
relation method to evaluate the correlation between the
two variables of the prevalence of coronavirus disease and
the HDI. The level of significance was set at less than 0.05.
The data were analyzed by Stata version 14 software.
3. Results
Appendix 1 in Supplementary File shows the number
of confirmed cases, new cases, and deaths by country. As
can be seen, most cases of coronavirus disease reported
by 30 April were in the United States of America (1,003,947
cases), Spain (212,917 cases), Italy (203,591 cases), the United
Kingdom (165,225 cases), and Germany (159,119 cases), in se-
quence.
Figure 1 shows the incidence of coronavirus disease per
100,000 population in different countries of the world.
Figure 2 shows the incidence of COVID-19 in some coun-
tries with high incidence during the last week of April. As
can be seen, in all countries, the incidence of the disease is
increasing, and the increasing slope in Qatar, and in other
countries, the slope is gentle and increasing.
Figure 3 shows the status of COVID-19 disease from 30
December 2019 to 30 April 2020 by WHO region.
The results demonstrated a significant positive corre-
lation between the Incidence of COVID-2019 and the HDI in
the world (r = 0.470, P < 0.0001) (Figure 4).
4. Discussion
Human coronavirus is one of the main respiratory
pathogens. As two highly pathogenic viruses, MERS-CoV
and SARS-CoV cause a severe respiratory syndrome in in-
dividuals while four other human coronaviruses (HCoV-
HKU1, HCoV-229E, HCoV-NL63, and HCoV-OC43) make mild
upper respiratory disease. The main SARS-CoV epidemic in-
fected 8,422 patients between 2002 and 2003 and extended
to 29 countries worldwide (11, 12). MERS-CoV spread in the
Middle East in 2012 (13, 14).
Phylogenetic analysis revealed that 2019-nCoV belongs
to the genus betacoronavirus, which includes (SARS-CoV,
bats such as SARS CoV and others) discovered in humans,
bats, and other wild animals. In a study carried out in
China, patients with COVID-19 had a fever, dry cough, indi-
gestion, and lung involvement in CT scans. Few patients
with 2019-nCoV infection showed symptoms in the up-
per respiratory tract (e.g., rhinorrhea, sneezing, and sore
throat) (15).
According to the studies done in China, patients ini-
tially presented with a mild cough and low-temperature re-
current fever without any evidence of pneumonia in chest
radiography. These nonspecific and mild symptoms in the
early clinical period of 2019-nCoV infection may not be clin-
ically detectable from many common infectious diseases
of winter (4, 15).
Studies in China showed that 2019-nCoV infections are
more common in men . MERS-CoV and SARS-CoV have also
been observed more in men than in women (16, 17). The
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Figure 2. The trend of Incidence of COVID-19 in some countries from 1 to 30 April 2020 (7)
lower susceptibility of women to the viral infection may
be related to the protection of the X chromosome and gen-
der hormones that play a considerable role in natural im-
munity (18). Moreover, about half of 2019-nCoV-infected
patients had chronic diseases, mostly cerebrovascular and
cardiovascular diseases, and diabetes; it is similar to MERS-
CoV in this aspect (16).
Host immune status is also an important factor. Ag-
ing, obesity, and comorbidities may be associated with in-
creased mortality. Populations with a poor immune func-
tion such as the elderly, diabetics, HIV sufferers, individu-
als with a long history of using immunosuppressive drugs,
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Figure 3. Epidemic curve of definite COVID-19 based on the date of the information and WHO districts by 30 April 2020 (7)
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Figure 4. Correlation between the HDI and COVID-19 incidence on 30 April 2020 (7)
and pregnant women are more likely to become infected
with 2019-nCoV infection. The immediate use of antibiotics
to avoid infection and boost the immune system may re-
duce the complications, morbidity, and mortality of the
disease (19). In laboratory tests, the absolute amount of
lymphocytes decreases in most patients. This shows that
2019-nCoV, similar to SARS-CoV, may affect lymphocytes, es-
pecially T lymphocytes.
The virus causes a series of immune reactions and
changes in white blood cells and immune cells, such as
lymphocytes. In some patients with ARDS and septic shock,
it progressed rapidly, eventually resulting in multiple or-
gan failure. Therefore, early detection and timely thera-
peutic actions are extremely important for critical cases
(4). The studies showed that saliva contains live viruses
and may cause transmission. Respiratory viruses can be
transmitted from an individual to another via direct or
indirect contact. Saliva is spread through the cough and
virus-containing respiratory droplets are found even dur-
ing normal breathing. Thus, 2019-nCoV may be transmit-
ted directly or indirectly through the saliva even from
patients without cough or other respiratory symptoms.
Therefore, the use of a mask can be considered a control
action (20, 21). Infection control measures should be im-
plemented and health authorities should be informed of
cases suspected of COVID-19 (22).
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Supplementary material(s) is available here [To read
supplementary materials, please refer to the journal web-
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